Structural-formula (Structural Formula)
Bendamustine Hydrochloride Injection, Solution
Product Images NDC 60505-6228
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 60505-6228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ctn-label-100mg (Ctn Label 100mg)
Bendamustine Hydrochloride Injection is a medication that is to be administered intravenously using a 500 mL infusion bag containing Sodium Chloride or Dextrose/Sodium Chloride prior to administration. The medication is available as a 4 mL Multiple-Dose Vial that needs to be stored in a refrigerator between 0 and 8°C. The vial contains 25 mg/mL of the active ingredient and the required dose must be diluted. The exact dosage is mentioned on the prescribing information. The medication is manufactured by Apotex Corp and contains hazardous agents that require cautious handling.*
Figure-1 (Image 02)
The text describes a graph displaying the survival distribution function for two treatments, Bendamustine Hydrochloride and Chlorambucil. The x-axis shows Progression-Free Survival measured in months. The y-axis displays the probability of survival.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
